LYPD6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.751800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.413000E-01
Normal-vs-Stage2
5.806400E-01
Normal-vs-Stage3
3.749400E-01
Normal-vs-Stage4
5.860200E-01
Stage1-vs-Stage2
5.913600E-01
Stage1-vs-Stage3
2.942600E-01
Stage1-vs-Stage4
4.579800E-01
Stage2-vs-Stage3
1.770020E-04
Stage2-vs-Stage4
5.427200E-01
Stage3-vs-Stage4
6.540000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.513400E-01
Normal-vs-AfricanAmerican
9.668400E-01
Normal-vs-Asian
5.491000E-01
Caucasian-vs-AfricanAmerican
3.549000E-01
Caucasian-vs-Asian
9.363800E-01
AfricanAmerican-vs-Asian
3.589600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.559400E-01
Normal-vs-Female
6.722000E-01
Male-vs-Female
6.949200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.414400E-01
Normal-vs-Age(41-60Yrs)
7.453200E-01
Normal-vs-Age(61-80Yrs)
3.950800E-01
Normal-vs-Age(81-100Yrs)
9.079000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.871400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.604400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.956200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.831630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.259600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.527200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.093800E-01
Normal-vs-Daily Drinker
5.952400E-01
Normal-vs-Weekly Drinker
6.126800E-01
Normal-vs-Occasional Drinker
8.561000E-01
Normal-vs-Social Drinker
5.048800E-01
Non Drinker-vs-Daily Drinker
9.034600E-01
Non Drinker-vs-Weekly Drinker
9.926000E-01
Non Drinker-vs-Occasional Drinker
2.517800E-01
Non Drinker-vs-Social Drinker
4.718000E-01
Daily Drinker-vs-Weekly Drinker
9.065800E-01
Daily Drinker-vs-Occasional Drinker
2.272600E-01
Daily Drinker-vs-Social Drinker
4.098000E-01
Weekly Drinker-vs-Occasional Drinker
2.735600E-01
Weekly Drinker-vs-Social Drinker
5.189200E-01
Occasional Drinker-vs-Social Drinker
5.355200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.894000E-01
Normal-vs-Grade 2
1.774440E-01
Normal-vs-Grade 3
1.663160E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.809400E-01
Grade 1-vs-Grade 3
1.312800E-01
Grade 1-vs-Grade 4
3.894000E-01
Grade 2-vs-Grade 3
6.181600E-01
Grade 2-vs-Grade 4
1.774440E-01
Grade 3-vs-Grade 4
1.663160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.606400E-01
Normal-vs-NonDiabetic
6.973800E-01
Diabetic-vs-NonDiabetic
4.726000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.382400E-01
Normal-vs-NoPancreatitis
3.918600E-01
Pancreatitis-vs-NoPancreatitis
8.605600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.198000E-01
Normal-vs-N1
5.814200E-01
N0-vs-N1
5.657800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.517800E-01
Normal-vs-TP53-NonMutant
8.885200E-01
TP53-Mutant-vs-TP53-NonMutant
6.982200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
